How severe is CVE-2022-37017?

High severity. CVSS v3 base score is 7.5 out of 10.

Is CVE-2022-37017 known to be exploited?

3 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.

Vulnerability in Broadcom Symantec Endpoint Protection

CVE-2022-37017

Symantec Endpoint Protection (Windows) agent, prior to 14.3 RU6/14.3 RU5 Patch 1, may be susceptible to a Security Control Bypass vulnerability, which is a type of issue that can potentially allow a threat actor to circumvent existing security controls. This CVE applies narrowly to the Client User Interface Password protection and Policy Import/Export Password protection, if it has been enabled.

Published 2022-12-01 · last modified 2026-06-17.

CVSS v3 metric

CVSS v3 base score 7.5 (High). Vector: CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:N/I:H/A:N.

EPSS exploit prediction

EPSS: 0.011 (64.8th percentile), scored 2026-09-29.

Low probability of exploitation in the next 30 days, but still tracked. 65th percentile — 64.8% of CVEs in the catalogue have a lower EPSS than this one. How to read EPSS.

EPSS over last 30 days · oldest: 0.011 · newest: 0.011 · change: +0.000

Affected products

Broadcom Symantec Endpoint Protection
Symantec Endpoint Protection — versions 14.3 RU5

Public proof-of-concept exploits

References

support.broadcom.com/web/ecx/support-content-notification/-/external/content/Se… (Permissions Required, Vendor Advisory)

Frequently asked questions

What is CVE-2022-37017?: CVE-2022-37017 is a high-severity vulnerability in Broadcom Symantec Endpoint Protection. CVSS score: 7.5/10. Published 2022-12-01.
How severe is CVE-2022-37017?: High severity. CVSS v3 base score is 7.5 out of 10.
Is CVE-2022-37017 known to be exploited?: 3 public proof-of-concept repositories are indexed. Not currently listed in the CISA KEV catalog.